| Name | Title | Contact Details |
|---|
Simio LLC is a privately held company that is dedicated to delivering leading edge solutions for the design, emulation, and scheduling of complex systems. A great place to ask technical questions and search other users comments is Simio Insiders: http:...
Luxor CRM is a North York, ON-based company in the Software and Internet sector.
JumpCrew is dedicated to helping businesses succeed. We partner with you to engage your customers, increase your revenue, and create recognition of your brand. Our company is built on a foundational understanding of the difficulties local businesses fa...
Selfbook makes booking reservations and managing guests and payments easy. Switch your hotel to this incredible software today!
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.